文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

近红外光免疫治疗诱导肿瘤细胞死亡增强肿瘤树突状细胞迁移。

Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration.

机构信息

Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Osaka, 584-8540, Japan.

Laboratory of Veterinary Physiology, Department of Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, 069-8501, Japan.

出版信息

Cancer Immunol Immunother. 2022 Dec;71(12):3099-3106. doi: 10.1007/s00262-022-03216-2. Epub 2022 May 28.


DOI:10.1007/s00262-022-03216-2
PMID:35624180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10673685/
Abstract

Near-infrared photoimmunotherapy (NIR-PIT) selectively kills tumor cells to which the photo-absorber dye IR700DX-conjugated antibodies are bound and induces a systemic anti-tumor immune response. NIR-PIT induces immunogenic cell death (ICD), releases damage-associated molecular patterns (DAMPs) molecules from dying tumor cells, and activates dendritic cells (DCs). However, it is unclear whether NIR-PIT affects migration of tumor-infiltrating (Ti)-DCs to draining lymph nodes (dLNs), where a systemic anti-tumor response is induced. Here, we utilized in vivo photolabeling of Ti-DCs in tumors in photoconvertible protein Kikume Green-Red (KikGR) mice to show that NIR-PIT enhanced migration of Ti-DCs including cDC1s, cDC2s, and CD326 DCs to dLNs. This effect was abolished by blocking adenosine triphosphate (ATP), one of the DAMPs molecules, as well as by inhibition of Gαi signaling by pertussis toxin. Thus, ICD induction by NIR-PIT stimulates Ti-DC migration to dLNs via ATP-P2X7 receptor and Gαi protein-coupled receptor signaling pathways and may augment tumor antigen presentation to induce anti-tumor T cells in dLNs.

摘要

近红外光免疫治疗(NIR-PIT)选择性地杀死与光吸收染料 IR700DX 结合的抗体结合的肿瘤细胞,并诱导全身性抗肿瘤免疫反应。NIR-PIT 诱导免疫原性细胞死亡(ICD),从死亡的肿瘤细胞中释放损伤相关分子模式(DAMP)分子,并激活树突状细胞(DC)。然而,目前尚不清楚 NIR-PIT 是否会影响浸润肿瘤的(Ti)-DC 向引流淋巴结(dLNs)的迁移,在那里诱导全身性抗肿瘤反应。在这里,我们利用可光转化蛋白 Kikume Green-Red(KikGR)小鼠肿瘤中 Ti-DC 的体内光标记,表明 NIR-PIT 增强了包括 cDC1s、cDC2s 和 CD326 DC 在内的 Ti-DC 向 dLNs 的迁移。这种作用被阻断三磷酸腺苷(ATP)所消除,ATP 是 DAMPs 分子之一,以及通过百日咳毒素抑制 Gαi 信号转导。因此,NIR-PIT 通过 ATP-P2X7 受体和 Gαi 蛋白偶联受体信号通路诱导 ICD,刺激 Ti-DC 向 dLNs 的迁移,并可能增强肿瘤抗原呈递,在 dLNs 中诱导抗肿瘤 T 细胞。

相似文献

[1]
Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration.

Cancer Immunol Immunother. 2022-12

[2]
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.

Oncotarget. 2017-2-7

[3]
Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity.

iScience. 2021-4-14

[4]
Phototruncation cell tracking with near-infrared photoimmunotherapy using heptamethine cyanine dye to visualise migratory dynamics of immune cells.

EBioMedicine. 2024-4

[5]
[Near Infrared Photoimmunotherapy for Cancer].

Gan To Kagaku Ryoho. 2019-1

[6]
Near-Infrared Photoimmunotherapy of Cancer.

Acc Chem Res. 2019-7-23

[7]
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.

Cancer Immunol Res. 2019-1-25

[8]
Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.

Cancer Immunol Res. 2020-1-17

[9]
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.

Int Immunol. 2021-1-1

[10]
Antitumor host immunity enhanced by near-infrared photoimmunotherapy.

Cancer Sci. 2025-3

引用本文的文献

[1]
Development of a silicon phthalocyanine analogue for near-infrared photoimmunotherapy and its application to HTLV-1-infected leukemic cells.

RSC Chem Biol. 2025-8-5

[2]
Phase-specific and laser-modulated polydopamine-chlorella-curdlan hydrogels: pioneering a melanoma integrative therapy.

Theranostics. 2025-6-23

[3]
Next-Generation Cancer Treatment: Photoimmunotherapy's Promise for Unresectable Head and Neck Cancers.

Pharmaceutics. 2025-5-29

[4]
Light-based technologies in immunotherapy: advances, mechanisms and applications.

Immunotherapy. 2025-2

[5]
Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions.

Front Oncol. 2024-12-5

[6]
Antitumor host immunity enhanced by near-infrared photoimmunotherapy.

Cancer Sci. 2025-3

[7]
Arbutin overcomes tumor immune tolerance by inhibiting tumor programmed cell death-ligand 1 expression.

Int J Med Sci. 2024-11-11

[8]
Molecular determinants of immunogenic cell death elicited by radiation therapy.

Immunol Rev. 2024-1

[9]
Nanomaterials for Skin Cancer Photoimmunotherapy.

Biomedicines. 2023-4-27

[10]
Ghost messages: cell death signals spread.

Cell Commun Signal. 2023-1-9

本文引用的文献

[1]
Cutting Edge: Recruitment, Retention, and Migration Underpin Functional Phenotypic Heterogeneity of Regulatory T Cells in Tumors.

J Immunol. 2021-8-1

[2]
Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity.

iScience. 2021-4-14

[3]
Tracking the fate and migration of cells in live animals with cell-cycle indicators and photoconvertible proteins.

J Neurosci Methods. 2021-5-1

[4]
Detection of immunogenic cell death and its relevance for cancer therapy.

Cell Death Dis. 2020-11-26

[5]
Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models.

Vaccines (Basel). 2020-9-14

[6]
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors.

Cancers (Basel). 2020-9-10

[7]
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.

Int Immunol. 2021-1-1

[8]
Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.

Cancer Immunol Res. 2020-1-17

[9]
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4 T Cell Immunity.

Cell. 2019-4-4

[10]
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.

Cancer Immunol Res. 2019-1-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索